Showing results (11-20 of 2,642) with videos related to

Sort By:
Pageof 265
Kidney International. Supplement|July 21, 1999
Ongoing clinical trials of lipid reduction therapy in patients with renal diseaseS Yukawa, M Mune, Y Yamada, et al.
Kidney International. Supplement|July 21, 1999
Evaluation of serum lipid abnormalities in chronic nephritisH Hirano, Y Yamada, H Otani, et al.
Kidney International. Supplement|July 21, 1999
Phospholipase A2 activity in ox-LDL-stimulated mesangial cells and modulation by alpha-tocopherolM Ozaki, Y Yamada, K Matoba, et al.
Nihon Jinzo Gakkai Shi|September 1, 1992
Study on the inhibitory effect of uremic plasma on lipoprotein lipaseS Yukawa, Y Tone, M Sonobe, et al.
Kidney International. Supplement|July 21, 1999
Lysophosphatidylcholine up-regulates IL-1 beta-induced iNOS expression in rat mesangial cellsM Taniuchi, H Otani, N Kodama, et al.
Kidney International. Supplement|July 21, 1999
Phosphotyrosine of macrophage by low-density lipoproteins from hemodialysis patientsM Sonobe, K Kimura, M Kishino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patientsS Yukawa, A Hibino, T Maeda, et al.
Nihon Jinzo Gakkai Shi|November 1, 1990
[Glomerular apolipoprotein B deposition in glomerular diseases]H Ohtani, K Matoba, Y Saika, et al.
Kidney International. Supplement|July 21, 1999
Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patientsM Mune, S Yukawa, M Kishino, et al.
Metabolism: Clinical and Experimental|October 1, 1984
Selective urinary excretion of phosphatidyl ethanolamine in patients with chronic glomerular diseasesK Mimura, S Yukawa, T Maeda, et al.
Pageof 265